Germany is the World’s Medical Cannabis Leader

 

AMP German Cannabis Group Inc. (“AMP”) is the only listed company that is focused on supplying Germany with pharmaceutical-grade (EU-GMP) cannabis. AMP purchases EU-GMP cannabis cultivated predominantly from Canada for import to Germany. AMP provides EU-GMP gap analysis, audit and German certification in addition to logistical, transportation, importation permits and other related services for the importation of medical cannabis into Germany through its AMP EU-GMP German Certification Protocol Program.

For more information contact us at info@amp-eu.com.

AMP trades on the FSE: C4T (ISIN: CA00176G1028) and the CSE: XCX

Download Our Investor Presentation